Level of Unawareness and Management of Diabetes, Hypertension, and Dyslipidemia among Adults in Luxembourg: Findings from ORISCAV-LUX Study

被引:33
作者
Alkerwi, Ala'a [1 ]
Pagny, Sybil [1 ]
Lair, Marie-Lise [1 ]
Delagardelle, Charles [2 ]
Beissel, Jean [2 ]
机构
[1] Ctr Rech Publ Sante CRP Sante, Dept Publ Hlth, Strassen, Grand Duchy Of, Luxembourg
[2] Ctr Hosp Luxembourg, Serv Cardiol, Luxembourg, Grand Duchy Of, Luxembourg
来源
PLOS ONE | 2013年 / 8卷 / 03期
关键词
CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; GENERAL-POPULATION; TASK-FORCE; PREVALENCE; AWARENESS; GUIDELINES;
D O I
10.1371/journal.pone.0057920
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: In the absence of evidence-based information, assessment of population awareness and management of diabetes, hypertension and dyslipidemia (treatable and preventable cardiovascular risk factors) are important to halt coronary and cerebrovascular diseases and to improve public health. Methods: The analysis was based on a nationally representative sample of 1432 adult subjects, recruited for the ORISCAV-LUX survey (2007-2008). Descriptive and multivariable logistic regression analyses were performed. The 10-year Framingham risk score was calculated for each participant who classified at low, intermediate and high risk. Results: Among the diagnosed cases, 32%, 60%, and 85% were respectively unaware of their diabetes, hypertension and dyslipidemia. Increasing age and BMI were the strongest protective factors against unawareness of hypertension and dyslipidemia. Having a family history decreased the risk of unawareness of hypertension (OR = 0.57; 95% CI 0.36, 0.92; P = 0.021), whereas, not having a family doctor increased double-fold the odd of being unaware of hypertension (P = 0.048). Poor health perception reduced significantly the risk of unawareness of dyslipidemia (OR = 0.27; 95% CI 0.11, 0.68). Concerning the management, diabetes was markedly better treated than hypertension and dyslipidemia. Among diabetic subjects (constituting 4% of the population), 3% were treated vs. 1% not treated. In contrast, 22% of the hypertensive participants (35% of the population) were not treated vs. 13% treated. Concerning dyslipidemia, only 9% of those with lipid disorder (70% of the population) were under medication vs. 61% not treated. For the treated cases of these pathologies, almost only one-third was under control. Framingham risk of developing CHD within 10 years was moderate to high among 62%, 27%, and 17% of the unaware/untreated diabetic, hypertensive, and dyslipidemic participants, respectively. Conclusion: The considerable lack of awareness and insufficient management underscore the urgent need for intensive efforts to reduce the gap in prevention strategies, and control of cases according to explicit clinical guidelines.
引用
收藏
页数:7
相关论文
共 26 条
  • [1] Aguado A, 2009, BMC GERIATR, V9, P16, DOI DOI 10.1186/1471-2318-9-16
  • [2] Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg
    Alkerwi, Ala'a
    Sauvageot, Nicolas
    Couffignal, Sophie
    Albert, Adelin
    Lair, Marie-Lise
    Guillaume, Michele
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2010, 10
  • [3] First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX)
    Alkerwi, Ala'a
    Sauvageot, Nicolas
    Donneau, Anne-Francoise
    Lair, Marie-Lise
    Couffignal, Sophie
    Beissel, Jean
    Delagardelle, Charles
    Wagener, Yolande
    Albert, Adelin
    Guillaume, Michele
    [J]. BMC PUBLIC HEALTH, 2010, 10
  • [4] Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc19-S002, 10.2337/dc12-S064, 10.2337/dc23-S002, 10.2337/dc09-S062, 10.2337/dc18-S002]
  • [5] Braun M, 2012, EUR J PREV CARDIOL
  • [6] Prevalence, Awareness, Treatment, and Control of Dyslipidemia among Adults in Beijing, China
    Cai, Li
    Zhang, Lei
    Liu, Aiping
    Li, Shuping
    Wang, Peiyu
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (02) : 159 - 168
  • [7] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [8] Prevalence, awareness, treatment and control of hypertension in healthy unrelated male-female pairs of European regions: the dietary habit profile in European communities with different risk of myocardial infarction - the impact of migration as a model of gene-environment interaction project
    Costanzo, Simona
    Di Castelnuovo, Augusto
    Zito, Francesco
    Krogh, Vittorio
    Siani, Alfonso
    Arnout, Jozef
    Cappuccio, Francesco P.
    Miller, Michelle A.
    van Dongen, Martien
    de Lorgeril, Michel
    de Gaetano, Giovanni
    Donati, Maria Benedetta
    Iacoviello, Licia
    [J]. JOURNAL OF HYPERTENSION, 2008, 26 (12) : 2303 - 2311
  • [9] Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study
    Danon-Hersch, Nadia
    Marques-Vidal, Pedro
    Bovet, Pascal
    Chiolero, Arnaud
    Paccaud, Fred
    Pecoud, Alain
    Hayoz, Daniel
    Mooser, Vincent
    Waeber, Gibrard
    Vollenweider, Peter
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (01): : 66 - 72
  • [10] European guidelines on cardiovascular disease prevention in clinical practice -: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice
    De Backer, G
    Ambrosioni, E
    Borch-Johnsen, K
    Brotons, C
    Cifkova, R
    Dallongeville, J
    Ebrahim, S
    Faergeman, O
    Graham, I
    Mancia, G
    Cats, VM
    Orth-Gomér, K
    Perk, J
    Pyörälä, K
    Rodicio, JL
    Sans, S
    Sansoy, V
    Sechtem, U
    Silber, S
    Thomsen, T
    Wood, D
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (17) : 1601 - 1610